AI Stock Monitor
UNH - UnitedHealth Group
UnitedHealth Group is a North America covered company in The Hedge Book research universe.
Public company · North America · Healthcare · Managed Health Care · Health Care Services · Dow constituent
0 followers · Follow to include this stock in your daily 9:30 AM Central watchlist email.
NYSE · Healthcare · Research updated · Market data updated Research and source refreshes run four times daily. The timestamps above identify the latest successful research and market-data updates.Price History
UNH chart
AI-Assisted Chart Analysis
UnitedHealth Group technical analysis
Calculated from verified chart history for the selected tenor; no news or fundamental assumptions are used.
Mixed trend: the latest level is below its 20-period average, without full long-term confirmation.
RSI is 28, a washed out reading. Above 70 can signal extension; below 30 can signal exhaustion.
The first technical watch zone is 330.48. A break below 330.48 invalidates the near-term support setup.
The first resistance/watch zone is 412.02. A confirmed break above 424.98 supports continuation.
Annualized realized volatility is +34.8%. Maximum lookback drawdown is -22.2%, from a high-water mark of 424.98 to 330.48.
Potential levels are conditional chart scenarios, not personalized advice or instructions to buy or sell.
How To Read This Stock Brief
Higher means the current research setup is stronger across signal, confidence, catalysts, risk balance, and market context. Lower means the setup is weaker or less supported.
Higher confidence means the evidence is more consistent and relevant. It does not mean the stock has that percentage chance of going up.
Bullish, Bearish, or Neutral is the current AI research stance. It is designed to help you ask better questions, not to replace your decision process.
This shows how signed-in users are voting. It is useful sentiment context, not proof that the crowd is right.
What Changed Today
- Yahoo Finance delayed market data reported UNH at 339.85 USD; the latest daily move rose +2.84%. This is a verified market-price signal only and does not by itself confirm a change in company fundamentals.
Why It Matters
- The verified +2.84% daily move is current market context for UnitedHealth Group.
- It can affect near-term sentiment, but price action alone does not establish a change in earnings, asset quality, competitive position, valuation, catalysts, or risks.
- Those require a separately sourced filing or company update.
AI Opinion
- Read: The signal is Bullish, driven by the recent analyst upgrade and the view that the market's reaction to regulatory news was excessive.
- Evidence: While the CMS audit proposal introduces genuine uncertainty for the Medicare Advantage segment, the company's diversified business model and scale provide a buffer that the market may be underappreciating.
- Uncertainty: The recent volatility reflects a 'fear' premium, and the current price levels may offer an attractive entry point for investors who believe the long-term growth thesis remains intact.
- Watch: A change in this view would require evidence of material downward revisions to earnings guidance or the implementation of regulatory changes that demonstrably impair core margins.
Key Risks
- Regulatory and legislative actions, specifically new CMS audit rules or 'Medicare for All' policy rhetoric, could materially compress margins in the Medicare Advantage business.
- Broader market volatility and sector rotation out of healthcare could continue to pressure the stock price, regardless of the company's underlying fundamental strength.
- Increased scrutiny on managed care profitability could lead to higher compliance costs and lower reimbursement rates, which would threaten the company's 13-16% long-term earnings growth target.
- The potential for further negative headlines regarding Medicare Advantage could trigger additional institutional selling, exacerbating short-term price instability.
Upcoming Catalysts
- Future earnings reports and management guidance updates will be the primary mechanism to confirm if the 13-16% long-term earnings growth target remains achievable in the current regulatory environment.
- Official CMS rulings or clarifications on the proposed audit rules will serve as a major catalyst, either alleviating or confirming investor fears regarding margin pressure.
- Any material capital allocation announcements, such as share buybacks or dividend increases, would signal management's confidence in cash flow generation and provide a floor for the stock price.
- Continued analyst support or upgrades from major firms could help rebuild investor confidence and reverse the recent negative sentiment trend.
Upcoming Events
No verified update available
Last Updated
Sources and verification
Each generated research claim remains linked to its supporting update. Primary evidence comes from filings, company materials, or regulators; secondary evidence provides additional context.
- Published stock briefSecondary sourceReportedStock Movers: Anthropic, Nvidia, UnitedHealth Group - Bloomberg.com · Published 2026-11-21 01:11:25Open verification sourceSupports: Published stock brief
- Published stock briefSecondary sourceReportedStock Market Today, Nov. 20: Stocks Plunge as AI Trade Unwinds · Published 2026-11-21 01:11:25Open verification sourceSupports: Published stock brief
- Published stock briefSecondary sourceAnalyst OpinionUNITEDHEALTH GROUP INC. INVESTIGATION: UNH Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights - Morningstar · Published 2026-11-21 01:11:25Open verification sourceSupports: Published stock brief
- Published stock briefSecondary sourceReportedTD Cowen names UnitedHealth its 2027 best idea, upgrades shares · Published 2026-11-21 01:11:25Open verification sourceSupports: Published stock brief
- Published stock briefSecondary sourceReportedSector Update: Healthcare Stocks Rise Late Afternoon · Published 2026-11-21 01:11:25Open verification sourceSupports: Published stock brief
Community View
Sign in with Google to vote once per stock.
Total votes: 0
Disclaimer
The Hedge Book provides AI-assisted educational market research. It is not a registered investment adviser, broker, dealer, or financial planner. Content may contain errors and should be independently verified. Do not treat this page as personalized advice to buy, sell, or hold any security.
